Jim Simons Gritstone Bio, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.46 - $4.75 $1.05 Million - $2.02 Million	-425,373 Reduced 84.25%	79,500 $204,000
Q2 2022 Aug 12, 2022	BUY	$1.77 - $4.34 $893,625 - $2.19 Million	504,873 New	504,873 $1.22 Million
Q3 2021 Nov 12, 2021	SELL	$6.41 - $13.54 $715,176 - $1.51 Million	-111,572 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $907,080 - $1.14 Million	111,572 New	111,572 $1.02 Million
Q1 2021 May 13, 2021	SELL	$4.07 - $27.11 $1.03 Million - $6.83 Million	-251,982 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$2.57 - $4.22 $216,954 - $356,243	-84,418 Reduced 25.09%	251,982 $993,000
Q3 2020 Nov 13, 2020	BUY	$2.63 - $8.09 $520,285 - $1.6 Million	197,827 Added 142.76%	336,400 $891,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $8.17 $506,825 - $727,726	89,073 Added 179.95%	138,573 $920,000
Q1 2020 May 14, 2020	BUY	$5.47 - $11.3 $270,765 - $559,350	49,500 New	49,500 $288,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.